Mycophenolate mofetil for autoimmune hepatitis: A single practice experience

Digestive Diseases and Sciences

Volumn 54, Issue 11, 2009, Pages 2519-2522

  Wolf, David C ^a   Bojito, Lizza ^a   Facciuto, Marcelo ^a   Lebovics, Edward ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Autoimmune hepatitis; Immunosuppression; Mycophenolate mofetil

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; URSODEOXYCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLANGITIS; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HUMAN; INFECTION; LEUKOCYTE COUNT; LEUKOPENIA; MUSCLE WEAKNESS; NAUSEA; PARESTHESIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RASH; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70350218797     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0632-0     Document Type: Article

References (18)

1. PD Richardson PD James SD Ryder 2000 Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine J Hepatol 33 371 375 10.1016/S0168-8278(00)80271-8 10.1016/S0168-8278(00)80271-8 11019991 (Pubitemid 30663373)
2. SM Devlin MG Swain SJ Urbanski KW Burak 2004 Mycophenolate moftil for the treatment of autoimmune hepatitis in patients refractory to standard therapy Can J Gastroenterol 18 321 326 15152283
3. N Chatur A Ramji VG Bain MM Ma PJ Marotta CN Ghent LB Lilly EJ Heathcote M Deschenes SS Lee UP Steinbrecher EM Yoshida 2005 Transplant immunosupressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus Liver Int 25 723 727 10.1111/j.1478-3231.2005.01107.x 10.1111/j.1478-3231.2005.01107.x 15998421 (Pubitemid 41038652)
4. AJ Czaja HA Carpenter 2005 Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease J Clin Gastroenterol 39 819 825 10.1097/01.mcg.0000177260.72692.e8 10.1097/01.mcg.0000177260.72692.e8 16145346 (Pubitemid 41361901)
5. I Inductivo-Yu A Adams RG Gish A Wakil NH Bzowej RT Fredercik M Bonacini 2007 Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy Clin Gastroenterol Hepatol 5 799 8082 10.1016/j.cgh.2007.02.030 10.1016/j.cgh.2007.02.030 17509945 (Pubitemid 47031057)
6. AJ Czaja DK Freese 2002 AASLD practice guidelines: diagnosis and treatment of autoimmune hepatitis Hepatology 36 479 497 10.1053/jhep.2002.34944 10.1053/jhep.2002.34944 12143059 (Pubitemid 34810370)
7. O Chazouilleres D Wendum L Serfaty O Rosmordgue R Poupon 2006 Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome J Hepatol 44 400 406 10.1016/j.jhep.2005.10.017 10.1016/j.jhep.2005.10.017 16356577 (Pubitemid 43069223)
8. A Floreani ER Rizzotto F Ferrara I Carderi D Caroli L Blasone V Baldo 2005 Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome Am J Gastroenterol 100 1516 1522 10.1111/j.1572-0241.2005.41841.x 10.1111/j.1572-0241.2005.41841.x 15984974 (Pubitemid 41032356)
9. RD Soloway WHJ Summerskill AH Baggenstoss MG Geall GL Gitnick IR Elveback LJ Schoenfield 1972 Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 820 833 4538724
10. IM Murray-Lyon RB Stern R Williams 1973 Controlled trial of prednisone and azathioprine in active chronic hepatitis Lancet 1 735 737 10.1016/S0140-6736(73)92125-9 10.1016/S0140-6736(73)92125-9 4121073
11. PJ Johnson IG McFarlane R Williams 1995 Azathioprine for long-term maintenance of remission in autoimmune hepatitis N Engl J Med 333 958 963 10.1056/NEJM199510123331502 10.1056/NEJM199510123331502 7666914
12. J Wiegand A Schuler S Kanzler A Lohse U Beuers W Kreisel U Spengler S Koletzko PL Jansen G Hochhaus HW Mollmann M Prols MP Manns 2005 Budesonide in previously untreated autoimmune hepatitis Liver Int 25 927 934 10.1111/j.1478-3231.2005.01122.x 10.1111/j.1478-3231.2005.01122.x 16162148 (Pubitemid 41404011)
13. A Csepregi C Rocken G Treiber P Malfertheiner 2006 Budesonide induces complete remission in autoimmune hepatitis World J Gastroenterol 12 1362 1366 16552802
14. NF Fernandes AG Redeker JM Vierling FG Villamil TL Fong 1999 Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis Am J Gastroenterol 94 241 248 10.1111/j.1572-0241.1999.00807.x 10.1111/j.1572-0241. 1999.00807.x 9934764 (Pubitemid 29063476)
15. M Cuarterolo M Ciocca CC Velasco M Ramonet T Gonzalez S Lopez A Garsd F Alvarez 2007 Follow-up of children with autoimmune hepatitis treated with cyclosporine J Pediatr Gastroenterol Nutr 44 18 19 10.1097/MPG.0b013e31802c8aa3 (Pubitemid 46071786)
16. FS Larsen B Vainer M Eefsen PN Bjjerring B Adel Hansen 2007 Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis World J Gastroenterol 13 3232 3236 17589903
17. RH Wiesner JS Shorr BJ Steffen AH Chu RD Gordon JR Lake 2005 Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C Liver Transpl 11 750 759 10.1002/lt.20453 10.1002/lt.20453 15973716 (Pubitemid 40975576)
18. United States Food and Drug Administration. MedWatch. www.fda.gov/medwatch/safety/2007/safety07.htm#CellCept2. Posted 29 October 2007. Accessed 19 November 2008.